Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christopher Mayo"'
Autor:
Ross Lawrenson, Sheena Moosa, Judy Warren, Ralph van Dalen, Lynne Chepulis, Tania Blackmore, Chunhuan Lao, Christopher Mayo, Jacquie Kidd, Melissa Firth, Tim Stokes, Mark Elwood, David Weller, Jon Emery
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background New Zealand has high rates of colorectal cancer (CRC) but poor outcomes. Most patients with CRC are diagnosed following referral from general practice, where a general practitioner (GP) assesses symptoms according to national guid
Externí odkaz:
https://doaj.org/article/1b75a0b0d9aa4146bf0e4d039d46ec46
Autor:
Ross Lawrenson, Ryan Paul, Chunhuan Lao, Rawiri Keenan, Brittany Morison, Christopher Mayo, Lynne Chepulis
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 4, Pp 318-326 (2020)
ABSTRACT INTRODUCTIONMetformin is the initial medication of choice for most patients with type 2 diabetes. Non-adherence results in poorer glycaemic control and increased risk of complications. AIMThe aim of this study was to characterise metformin a
Externí odkaz:
https://doaj.org/article/63386f3f648a4f1380719a9fd98080b9
Autor:
Christopher Mayo
Publikováno v:
New Zealand Medical Student Journal, Vol 0, Iss 33 (2021)
Rates of illicit substance use (ISU) in New Zealand are currently amongst the highest in the world, and ISU generates a national disease burden of 9,700 disability-adjusted life years per annum. I propose decriminalisation of personal possession and
Externí odkaz:
https://doaj.org/article/12c00a71d96345d4a8eb6c485346a577
Autor:
Christopher Mayo
Publikováno v:
New Zealand Medical Student Journal, Vol 0, Iss 32 (2021)
The Global Burden of Diseases, Injury, and Risk Factors Study (GBD) is a study that aims to quantify the worldwide health impacts of a number of diseases and risk factors. An article by Karimkhani et al from the 2013 iteration of the GBD study claime
Externí odkaz:
https://doaj.org/article/469a38371764438ca9feac23010e318b
Publikováno v:
The New Zealand medical journal. 135(1548)
To determine what the variation was in the initial use of vildagliptin in patients with type 2 diabetes following approval of open access funding in October 2018, including by ethnicity, gender, age, funding model and patient HbA1c levels.Data were c
Publikováno v:
International Journal of Buddhist Thought and Culture. 30:39-76
Autor:
Lynne Chepulis, Christopher Mayo, Chunhuan Lao, Rawiri Keenan, Ross Lawrenson, Ryan G. Paul, Brittany Morison
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 4, Pp 318-326 (2020)
ABSTRACT INTRODUCTIONMetformin is the initial medication of choice for most patients with type 2 diabetes. Non-adherence results in poorer glycaemic control and increased risk of complications. AIMThe aim of this study was to characterise metformin a
Publikováno v:
The New Zealand medical journal. 134(1528)
Publikováno v:
Internal medicine journalReferences. 51(5)
BACKGROUND It is well known that tight glycaemic control reduces all-cause mortality and the development of microvascular complications in patients with type 1 diabetes mellitus (T1D), but that effective glycaemic control is difficult to achieve in d
Publikováno v:
Revista Fuentes El Reventón Energético, Vol 20, Iss 2, Pp 23-41 (2022)
El presente documento muestra la realidad, desafíos y perspectivas de recuperación secundaria del reservorio “U Inferior” (UI) en el campo Sacha, localizado al flanco occidental del “Play Central” (Corredor Sacha-Shushufindi) del oriente ec
Externí odkaz:
https://doaj.org/article/08ab48c596f14e4fa5565a82319ca03c